Tuesday, Eli Lilly (NYSE:LLY) received continued support from BMO Capital with a reiteration of its Outperform rating and a $1,101.00 price target. The pharmaceutical giant... ByInvesting.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback